Start as an Emergency Physician

This is a disease of wealth, and ordinary people have only one way to die if they get this disease.

At this point, Haoyue is relatively lucky, at least she can afford the high cost of treatment.

After seeing the nurse hang the stem cell suspension on the infusion stand and start the intravenous infusion of Haoyue, Zhou Yuan and He Jianyi both breathed a sigh of relief.

The two left the transplant chamber and prepared to return to the emergency department.

Liu Huimin has also been sent to the general ward, during which time she has taken a leave of absence, and the work at the hospital has been replaced by someone else.

He Jianyi looked at Zhou Yuan who was walking beside him, and his heart was full of shock.

"When did you learn so well about bone marrow transplantation..."

This technique is not difficult, but, like suturing, being able to do it and achieving a high level are completely two different concepts.

And Zhou Yuan's bone marrow transplant technology is much better than that of doctors in hematology and oncology, and it is obviously a high-level rank...

He Jianyi estimated that if the original survival rate was only 10%, the main knife of bone marrow transplantation was replaced by Zhou Yuan, and the success rate might be increased to 40%!

For an individual, this number is high, but it is not a horror, after all, there is still a 60% mortality rate.

But...... If you look at the group of bone marrow transplants, then 30% of the patients who are destined to die will be given a new life!

"Zhou Yuan, how did you do it..."He Jianyi couldn't help but ask.

Zhou Yuan: "Epiphany." "

He Jianyi laughed helplessly: "Since you don't want to say it, I can only be gifted when you have it... There is no other explanation than this. However, your talent is terrifying!"

Zhou Yuan sighed.

It was really an epiphany.

"You say yes, system?"

The system said perfunctorily: "Yes, yes, yes." "

The two continued to walk forward, and when they arrived at the lounge, He Jian stopped consciously, but Zhou Yuan continued to walk forward.

"Zhou Yuan, aren't you resting in the lounge?"

Zhou Yuan straightened the badge on his chest and said, "Teacher, I'm already a resident now." "

He Jian was stunned and a little surprised.

Twenty-six-year-old resident... It's a bit scary.

"Let's go, I'll show you around your office. "

As he spoke, He Jianyi led Zhou Yuan to the public office.

Zhou Yuan paused and said, "Teacher, my office is independent..."

"Oh, independent... Independent?!"

This time, He Jianyi was really scared.

He has worked hard in this emergency department for twenty or thirty years, and he was easily promoted to deputy chief physician, so he has an office, Zhou Yuan has only been in the hospital for more than a month...

Zhou Yuan smiled and nodded, and took it to his new office.

The office is not big, about the size of the dean's office.

He Jianyi was already a little dumbfounded, "Dean Fang values you too much." "

However, this is not incomprehensible.

With Zhou Yuan's surgical level, it is not inconceivable to have an independent office.

"Teacher, how are you handling the new thrombolytic drugs?"

Zhou Yuan opened the door of his office and invited He Jianyi in.

He Jianyi sat down and said with some concern: "Do you know Director Zhao Lei Zhao from the personnel department of the hospital, Zhao Lei is my classmate with Liu Huimin when I was in college, and she is the director of the personnel department, one level older than me and Liu Huimin." "

"Zhao Lei's husband is the general manager of Huiwei Pharmaceutical Group, and it can be said that he is the person in charge of Huiwei Pharmaceutical Group on the bright side, called Fang Zhijun, who bought my ex-wife Mei Lan to let me sign. "

"Fang Zhijun thought that I would sign in front of Mei Lan as my ex-wife, it was so naïve... I will never help Huiwei Pharmaceutical Group cover up the ugly truth!"

Zhou Yuan nodded, and asked again, "How is the process on the Food and Drug Administration?"

It is impossible to expose and report the new thrombolytic drug of Huiwei Pharmaceutical Group with the Food and Drug Administration, which is followed by billions of dollars in profits, and such a huge return is enough to clear all obstacles on the road to market.

"It is still under approval, and I estimate that in three months at most, this new thrombolytic drug will appear on the market, and the price of the drug is estimated to be between thousands and 10,000. "

Of course, those doctors who agree to change their signatures on the expert certificate may be much cheaper, and it is estimated that they can get it for about 1,000.

This is an incredibly tempting condition. A box of medicine is cheaper than five or six thousand, seven or eight thousand, and according to the flow of patients in the hospital, the number of medicines issued is extremely terrifying...

"There's a great temptation indeed. Zhou Yuan sighed.

The cost of medicine is not worth so much money, at most it is only a few hundred yuan, but once it is made into medicine, it is a sparse and common thing to increase the price several times or even dozens of times.

Because the research of a new drug is time-consuming and costly, the research cycle is long, and the investment is extremely huge.

Take Gleevec, which can treat the chronic myeloid leukemia that Haoyue suffers from.

Before the advent of Gleevec, humans were almost helpless against chronic myeloid leukemia, with no choice but to wait for a bone marrow transplant or endure the painful disruption of chemotherapy.

However, it took 50 years for Novartis in Switzerland and a large number of experts to devote their lives to the research of Gleevec, and finally, after spending more than 5 billion US dollars, Gleevec was born.

This drug has turned chronic myeloid leukemia, which can only wait for death, into a disease that can be controlled by drugs like hypertension and diabetes, and as long as Gleevec is taken, patients with chronic myeloid leukemia can live like ordinary people.

Therefore, those who have not been able to wait for a bone marrow transplant can use Gleevec to prolong their lives.

But...... A box of Gleevec costs as much as 25,000 RMB!

It is also a life-saving medicine that needs to be taken for a long time, so ordinary people simply cannot afford it.

Say it's expensive, outrageous?

However, it took the efforts of countless experts to manufacture and develop Gleevec, and for 50 years, countless expert teams worked day and night to tackle tough problems, paying more than 5 billion US dollars...

If the price of drugs is not high, how can these costs be recovered?

Pharmaceutical companies are not charities, experts are not saints, and no one will spend energy on researching new drugs without profit, and without new drugs, the victims will still be patients waiting for new drugs.

These pharmaceutical companies are like buying lottery tickets, if they develop it, then they make a lot of money, but if they have been researching for decades and there is no progress... It's equivalent to all the investment being wasted.

Back to Huiwei Pharmaceutical Group, the same is true.

To develop a new type of thrombolysis, Huiwei Pharmaceutical Group invested a large number of experts and spent more than one billion.

If the drug is successfully listed, then Huiwei Pharmaceutical Group can obtain billions of profits, but if the new thrombolytic finally dies and is stopped by the Food and Drug Administration, they will suffer a loss of more than a billion yuan, which is not counting the R&D efforts of a large group of experts..._

Feilu reminds you: there are three things to read - collection, recommendation, and points